BR0016021A - Processo de tratamento de doenças do trato gastrointestinal com agonistas do receptor purinérgico - Google Patents
Processo de tratamento de doenças do trato gastrointestinal com agonistas do receptor purinérgicoInfo
- Publication number
- BR0016021A BR0016021A BR0016021-0A BR0016021A BR0016021A BR 0016021 A BR0016021 A BR 0016021A BR 0016021 A BR0016021 A BR 0016021A BR 0016021 A BR0016021 A BR 0016021A
- Authority
- BR
- Brazil
- Prior art keywords
- gastrointestinal tract
- diphosphate
- triphosphate
- gastrointestinal
- provides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"PROCESSO DE TRATAMENTO DE DOENçAS DO TRATO GASTROINTESTINAL COM AGONISTAS DO RECEPTOR PURINéRGICO". A invenção apresenta um processo para regular as secreções de água e mucina e o transporte de fluido no trato gastrointestinal. A invenção também apresenta um processo para o tratamento de uma doença gastrointestinal, em que a barreira mucosa do sistema gastrointestinal esteja prejudicada. A invenção também apresenta um processo para corrigir distúrbios de secreção ou absorção de fluidos no sistema gastrointestinal. O processo compreende a administração a um paciente de um composição farmacêutica compreendendo um agonista de receptor P2Y purinérgico, em uma quantidade eficaz para regular as secreções de água e mucina ou para corrigir o transporte anormal de fluido no trato gastrointestinal. A composição farmacêutica usada nesta invenção compreende um agonista de receptor purinérgico P2Y, como 5'-difosfato de uridina (UDP), 5'trifosfato de uridina (UTP), 5'-difosfato de citidina (CDP), 5'-trifosfato de citidina (CTP), 5'-difosfato de adenosina (ADP), 5'-trifosfato de adenosina (ATP), e seus análogos; e compostos de polifosfato de dinucleotídeo de Fórmula genérica (IV). O composto é preparado em uma forma oral, uma forma injetável ou uma forma de supositório, e é administrado a um paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17171099P | 1999-12-22 | 1999-12-22 | |
PCT/US2000/035439 WO2001045691A2 (en) | 1999-12-22 | 2000-12-22 | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0016021A true BR0016021A (pt) | 2003-07-15 |
Family
ID=22624842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0016021-0A BR0016021A (pt) | 1999-12-22 | 2000-12-22 | Processo de tratamento de doenças do trato gastrointestinal com agonistas do receptor purinérgico |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1261323A2 (pt) |
JP (1) | JP2003524636A (pt) |
KR (1) | KR20020069218A (pt) |
CN (1) | CN1413113A (pt) |
AU (1) | AU2603101A (pt) |
BR (1) | BR0016021A (pt) |
CA (1) | CA2395108A1 (pt) |
MX (1) | MXPA02005161A (pt) |
WO (1) | WO2001045691A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7629329B2 (en) | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
WO2003039473A2 (en) * | 2001-11-06 | 2003-05-15 | Inspire Pharmaceuticals, Inc. | Method for treating or preventing inflammatory diseases |
US7049303B2 (en) * | 2001-11-07 | 2006-05-23 | Medical Research Council | Inhibition of viruses |
TWI263505B (en) * | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
EP1348466A3 (en) | 2002-02-01 | 2003-10-29 | Inspire Pharmaceuticals, Inc. | Method for treating pain with adenosine-tetraphosphates |
US6683060B2 (en) * | 2002-02-25 | 2004-01-27 | Advanced Gene Technology Corp. | Matrix metalloproteinase and tumor necrosis factor inhibitors |
AU2003217863B9 (en) | 2002-02-28 | 2009-10-29 | Biota Scientific Management Pty Ltd | Nucleotide mimics and their prodrugs |
GB0312844D0 (en) * | 2003-06-04 | 2003-07-09 | Paradigm Therapeutics Ltd | Use of compounds in medicine |
JP5092400B2 (ja) * | 2004-06-28 | 2012-12-05 | 味の素株式会社 | 栄養組成物および消化管機能低下予防・改善用組成物 |
BRPI0515413B8 (pt) * | 2004-09-17 | 2021-05-25 | Ajinomoto Kk | uso de um sal de ácido glutâmico com aminoácido básico |
JP5408882B2 (ja) * | 2008-01-23 | 2014-02-05 | ヤマサ醤油株式会社 | 唾液分泌促進剤 |
GB201320959D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
GB201320962D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
EP3962493A2 (en) | 2019-05-03 | 2022-03-09 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7395094A (en) * | 1993-10-15 | 1995-05-04 | Wisconsin Alumni Research Foundation | Substituted purine nucleoside analogs and method for treating endotoxin shock |
US5837861A (en) * | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
CN1262556C (zh) * | 1997-02-06 | 2006-07-05 | 印斯拜尔药品股份有限公司 | 特定的二核苷酸和它们作为粘膜纤毛清除和纤毛颤动频率调节剂的应用 |
AU3612600A (en) * | 1999-02-26 | 2000-09-14 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
-
2000
- 2000-12-22 MX MXPA02005161A patent/MXPA02005161A/es unknown
- 2000-12-22 CA CA002395108A patent/CA2395108A1/en not_active Abandoned
- 2000-12-22 WO PCT/US2000/035439 patent/WO2001045691A2/en not_active Application Discontinuation
- 2000-12-22 JP JP2001546630A patent/JP2003524636A/ja active Pending
- 2000-12-22 BR BR0016021-0A patent/BR0016021A/pt not_active Application Discontinuation
- 2000-12-22 CN CN00817607A patent/CN1413113A/zh active Pending
- 2000-12-22 AU AU26031/01A patent/AU2603101A/en not_active Abandoned
- 2000-12-22 KR KR1020027007963A patent/KR20020069218A/ko not_active Application Discontinuation
- 2000-12-22 EP EP00989533A patent/EP1261323A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2603101A (en) | 2001-07-03 |
EP1261323A2 (en) | 2002-12-04 |
CN1413113A (zh) | 2003-04-23 |
MXPA02005161A (es) | 2002-12-09 |
JP2003524636A (ja) | 2003-08-19 |
CA2395108A1 (en) | 2001-06-28 |
WO2001045691A3 (en) | 2002-04-18 |
WO2001045691A2 (en) | 2001-06-28 |
KR20020069218A (ko) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0016021A (pt) | Processo de tratamento de doenças do trato gastrointestinal com agonistas do receptor purinérgico | |
US5972904A (en) | Method of treating sinusitis with uridine triphosphates and related compounds | |
US6423694B1 (en) | Method of treating otitis media with uridine triphosphates and related compounds | |
JP4271730B2 (ja) | ウリジン三リン酸及び関連化合物による線毛ジスキネシアの治療方法 | |
US20020155150A1 (en) | Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients | |
MY120023A (en) | Method of treating dry eye disease with uridine triphosphates and related compounds. | |
MXPA01008547A (es) | Metodo para promover la hidratacion de mucosas con ciertos difosfatos de uridina, adenina y citidina, y analogos de estos. | |
WO1997035591A9 (en) | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds | |
ATE261982T1 (de) | Salze von di(uridine 5'-tetraphosphate), verfahren zur herstellung und verwendungen davon | |
BR9912896A (pt) | Nucleotìdeos beta-l-2' -dioxi para tratamento de hepatite b | |
BR0110418A (pt) | Método para tratamento da degeneração retiniana com agonistas do receptor purinérgico | |
US6420347B1 (en) | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds | |
KR20050043761A (ko) | 염증성 질환의 치료 또는 예방 방법 | |
US6673779B2 (en) | Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues | |
BRPI0409088A (pt) | composições farmacêuticas para administração intranasal de ácido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0]non-1(7)-en-2-il)alquil]-fosfÈnico e derivados e métodos de uso dos mesmos | |
CN102317300A (zh) | 制造核苷四磷酸类似物的方法 | |
US4044122A (en) | Method of treating herpes virus hominis infections | |
EP1786441A2 (en) | Method and means for enhanced pulmonary drug delivery | |
MXPA99000011A (en) | Method for treating sinusitis with trifosphates deuridine and relative compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |